MicroRNAs (miRNAs) are very powerful genetic regulators, as evidenced by the fact that a
single miRNA can direct entire cellular pathways via interacting with a broad spectrum of …

Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer
therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using …

Cancer has become the second greatest cause of death worldwide. Although there are
several different classes of anticancer drugs that are available in clinic, some tough issues …

Breast cancer is the most common cancer in women worldwide. MicroRNAs (miRNAs) are
non-coding RNAs that are involved in the post-transcriptional regulation of gene expression …

Bio-based nanomaterials have received considerable attention in cancer therapies due to
their potent characteristics such as autologous pharmaceutical, synergetic effects …

Breast cancer is becoming one of the main lethal carcinomas in the recent era, and its
occurrence rate is increasing day by day. There are different breast cancer biomarkers, and …

The discovery of the link between microRNAs (miRNAs) and a myriad of human diseases,
particularly various cancer types, has generated significant interest in exploring their …

Breast cancer is commonly known life-threatening malignancy in women after lung cancer.
The standard of care (SOC) treatment for breast cancer primarily includes surgery …

The rapid development of nanotechnology has generated numerous ideas for cancer
treatment, and a wide variety of relevant nanoparticle platforms have been reported. Metal …

Nucleic acids provide a promising therapeutic platform by targeting various cell signaling
pathways involved in cancer and genetic disorders. However, maintaining optimal stability …